Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells
Drug resistance in epithelial ovarian cancer (EOC) is reportedly attributed to the existence of cancer stem cells (CSC), because in most cancers, CSCs still remain after chemotherapy. To overcome this limitation, novel therapeutic strategies are required to prevent cancer recurrence and chemotherapy...
Main Authors: | Heejin Lee, Jun Woo Kim, Dae Kyung Kim, Dong Kyu Choi, Seul Lee, Ji Hoon Yu, Oh-Bin Kwon, Jungsul Lee, Dong-Seok Lee, Jae Ho Kim, Sang-Hyun Min |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2327 |
Similar Items
-
Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness
by: Heejin Lee, et al.
Published: (2020-10-01) -
Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells
by: Heejin Lee, et al.
Published: (2021-04-01) -
N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis
by: Mingming Zhao, et al.
Published: (2023-02-01) -
Calcium Channels in the Heart: Disease States and Drugs
by: Kajol Shah, et al.
Published: (2022-03-01) -
Corrected QT interval in electrocardiogram recordings
in patients treated with calcium channel blockers
by: Małgorzata Wołek, et al.
Published: (2023-06-01)